Midwest pediatric device consortium (mpdc)
Active Project Grant Awarded Last action
- Award ID
- P50FD007961
- Recipient
-
Research Institute At Nationwide Children's Hospital UEI EYMJXLN2MFB4 Part of Nationwide Childrens Hospital
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $5,750,000
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date 63% complete
- Funding agency
- Center for Devices and Radiological Health Food and Drug Administration, Department of Health and Human Services
- Place of performance
- Columbus, OH 43205, USA
Award details come from USAspending.gov.
Description
- Abstract
- The midwest pediatric device consortium (mpdc) has been created to address unmet needs in pediatric medical device development. Founded at nationwide children's hospital (NCH) and the ohio state university (OSU) in columbus, ohio, mpdc will use funds from the FDA pediatric device consortia (PDC) program in support of its mission to provide funding and business, legal, organizational, clinical, engineering and scientific resources to inventors of pediatric medical devices having significant commercialization potential and that address pediatric health needs. NCH and OSU both maintain national prominence in clinical care and research. Teaming with other pediatric healthcare organizations including cincinnati children's and cleveland clinic children's establishes a vibrant and comprehensive medical device development ecosystem for our region and provides diversity in leadership, participation, community engagement and economic opportunity. Mpdc is also powered by ohio's trade organizations, including jobs ohio and ohio life sciences, to leverage their network of connections and state legislative influence. Lastly, mpdc engages with several venture funds including REV1 ventures, cincytech, and project medtech, having considerable resources and experience bringing startup companies forward. Participating organizations of the mpdc have already assisted a large number of devices along the development pathway, demonstrating the business experience and stewardship of ideas necessary for programmatic success. The full range of support is offered to innovators by the mpdc network, comprised of preeminent experts in their field who will provide advice, education, guidance and funding to help lead device development through the pipeline to commercial success. Our executive committee and advisory committee are made up of clinicians, scientists, business and manufacturing experts who are thought-leaders in their fields. They will evaluate the clinical and business merits of every device project submitted for evaluation and funding. Mpdc's organizational structure includes a broad spectrum of leaders who are able to assess the value proposition, reimbursement, regulatory, marketing and business strategy of each proposed device as a cost-free service. Mpdc will implement its comprehensive plan to foster collaboration, diversity, equity, and inclusion as a leader in creating a national network benefiting all pediatric patients mpdc will also provide unique real world evidence through projects specifically crafted to capture data streams as well as develop mechanisms to collect new data to support pediatric device label expansion. Mpdc will be a beacon of pediatric medical device innovation through its bridging of academic researchers, inventors, entrepreneurs and industry partners in an integrative program to transform pediatric healthcare through advancement of new and needed technologies.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,150,000 | |
| Amendment | $1,150,000 | |
| Amendment | $1,150,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,150,000 | |
| Original award | $1,150,000 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Bloom Standard, Inc. | $50,000 | |
| Global Continence, Inc. | $60,000 | |
| Heartpoint Global Inc. | $75,000 | |
| Kilele Health Inc. | $30,000 | |
| Childrens Hospital Medical Center | $38,054 | |
| The Cleveland Clinic Foundation | $36,108 | |
| Navi Medical Technologies Inc. | $50,000 | |
| Esperto Medical Inc. | $50,000 | |
| Eclipse Regenesis, Inc. | $50,000 | |
| Spinex Inc. | $50,000 | |
| Rhaeos, Inc. | $50,000 | |
| Lighthanded Enterprises Inc. | $50,000 | |
| The Ohio State University | $238,899 |
Show all 13
Quick answers
Who received award P50FD007961?
P50FD007961 was awarded to Research Institute At Nationwide Children's Hospital by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 1, 2023.
How much is award P50FD007961 worth?
$5,750,000 has been obligated on P50FD007961.
Which agency awarded P50FD007961?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded P50FD007961, with funding from Center for Devices and Radiological Health (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award